Trial: 202111197

A Phase I/IIa Multi-center, Open-label Master Protocol to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Antitumor Activity of AZD8205 in Participants with Advanced or Metastatic Solid Malignancies



Principal Investigator

Park, Haeseong

Disease Site

Anus; Breast; Cervix; Colon; Corpus Uteri; Esophagus; Liver; Other Digestive Organ; Other Female Genital; Ovary; Pancreas; Rectum; Small Intestine; Stomach

Learn more about this study at: